New Jersey is halting use of Johnson & Johnson’s one-shot vaccine at sites across the state. The decision comes after the Centers for Disease Control and Prevention and the Food and Drug Administration recommended a “pause” in administration of the vaccine “out of an abundance of caution” while they investigate six cases of women who developed rare but severe blood clots after receiving the vaccine.
On Tuesday, the state Department of Health said that appointments for Johnson & Johnson vaccinations will be canceled or put on hold until further notice — and that it will help anyone scheduled for that vaccine to instead get the Pfizer or Moderna vaccine, neither of which has been associated with the clots. Gov. Phil Murphy emphasized the reported cases of blood clots are extremely rare.
Montclair State University professor and epidemiologist Dr. Stephanie Silvera helped make sense of the information that came out Monday.